Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Srikanth Vallurupalli and Jawahar Mehta.
|
|
Connection Strength |
|
|
|
|
|
1.601 |
|
|
|
-
Vallurupalli S, Shanbhag A, Mehta JL. Controversies in postoperative atrial fibrillation after noncardiothoracic surgery: clinical and research implications. Clin Cardiol. 2017 May; 40(5):329-332.
Score: 0.583
-
Ayan M, Gheith Z, Ananthula A, Salih M, Vallurupalli S, Mehta JL. Multiple admissions to the coronary care unit due to falsely elevated cardiac troponin. Proc (Bayl Univ Med Cent). 2018 Apr; 31(2):197-199.
Score: 0.157
-
Mathur P, Thanendrarajan S, Paydak H, Vallurupalli S, Jambhekar K, Bhatti S, Schinke CD, Davies FE, Mehta JL. Cardiovascular complications of multiple myeloma in the elderly. Expert Rev Cardiovasc Ther. 2017 Dec; 15(12):933-943.
Score: 0.153
-
Dai Y, Cao Y, Zhang Z, Vallurupalli S, Mehta JL. Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation. Cardiovasc Drugs Ther. 2017 Feb; 31(1):19-27.
Score: 0.145
-
Pothineni NV, Rochlani Y, Vallurupalli S, Kovelamudi S, Ahmed Z, Hakeem A, Mehta JL. Comparison of Angiographic Burden of Coronary Artery Disease in Patients With Versus Without Hepatitis C Infection. Am J Cardiol. 2015 Oct 01; 116(7):1041-4.
Score: 0.130
-
Pothineni NV, Delongchamp R, Vallurupalli S, Ding Z, Dai Y, Hagedorn CH, Mehta JL. Impact of hepatitis C seropositivity on the risk of coronary heart disease events. Am J Cardiol. 2014 Dec 15; 114(12):1841-5.
Score: 0.123
-
Raina S, Pant S, Vallurupalli S, Jambhekar K, Pandey T, Grazziutti M, Barlogie B, Dai Y, Deshmukh A, Mehta JL. Can autologous bone marrow transplantation improve systolic function in patients with multiple myeloma related cardiac amyloidosis? Int J Cardiol. 2014 Mar 01; 172(1):265-6.
Score: 0.117
-
Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022 02 05; 21(1):20.
Score: 0.051
-
Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. Am Heart J. 2021 03; 233:86-91.
Score: 0.047
-
Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. Am Heart J. 2021 02; 232:10-22.
Score: 0.047
-
Subramany S, Kattoor AJ, Kovelamudi S, Devabhaktuni S, Mehta JL, Vallurupalli S, Paydak H, Pothineni NVK. Utility of Inferior Lead Q-waveforms in diagnosing Ventricular Tachycardia. Clin Med Insights Cardiol. 2020; 14:1179546820953416.
Score: 0.046
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|